Skip to content

Hypertension Evaluation Project III

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN53383289
Enrollment
8325
Registered
2007-11-06
Start date
2004-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension Circulatory System Hypertension

Interventions

1. Guideline in print 2. Interactive guideline 3. Expert seminars 4. Control group The intervention groups were 3825 physicians for the expert seminars and always 1500 for the guideline in print, the

Sponsors

University of Cologne (Germany)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Participants of HEP I-trial: In the HEP-I trial we explored the guideline awareness of 24899 German physicians, including all internists, cardiologists and 22% of general practitioners in a nationwide survey. The data is already published (see http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=11677375)

Exclusion criteria

Exclusion criteria: See inclusion criteria.

Design outcomes

Primary

MeasureTime frame
Difference in guideline awareness between trained physicians and the control group.

Secondary

MeasureTime frame
Overall guideline awareness.

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 5, 2026